Methylation status of ORMDL3 regulates cytokine production and p-ERK/MMP9 pathway expression

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Orosomucoid like-3 (ORMDL3) is linked to asthma development, but its precise role in pathogenesis is unclear.
• Asthma involves increased cytokine production and specific signaling pathway activation.

Purpose of the Study:

• To investigate the role of ORMDL3 in childhood asthma.
• To explore the relationship between ORMDL3, cytokines, the p-ERK/MMP-9 pathway, and DNA methylation.

Main Methods:

• Examined ORMDL3 expression in peripheral blood mononuclear cells (PBMCs) from childhood asthma patients and controls.
• Assessed cytokine production (IL-6, IL-8) and p-ERK/MMP-9 pathway activation.
• Investigated the effect of 5-Aza-CdR (a DNA methylation inhibitor) on ORMDL3 expression and promoter activity.
• Utilized ORMDL3 knockdown experiments in vitro and in normal human bronchial epithelial (NHBE) cells.

Main Results:

• ORMDL3 was highly expressed in childhood asthma patients, correlating with increased IL-6, IL-8, and p-ERK/MMP-9 pathway activation.
• ORMDL3 overexpression in vitro induced IL-6 and IL-8 release and activated the p-ERK/MMP-9 pathway.
• 5-Aza-CdR treatment increased ORMDL3 expression by demethylating its promoter region, leading to elevated IL-6 and IL-8 levels in NHBE cells.
• Knockdown of ORMDL3 reduced p-ERK/MMP-9 pathway expression, with or without 5-Aza-CdR treatment.

Conclusions:

• ORMDL3 is associated with asthma-related cytokine production and pathway activation.
• DNA methylation is a key regulator of ORMDL3 expression, influencing IL-6, IL-8 levels, and p-ERK/MMP-9 pathway activity in asthma.
• Findings elucidate a novel mechanism involving ORMDL3 and DNA methylation in childhood asthma pathogenesis.